ACM
REGN icon

Anfield Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Anfield Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2
Closed -$1.93K – 511
2024
Q1 		$1.93K Buy
+2
New +$1.9K ﹤0.01% 253
2023
Q1 		– Sell
-228
Closed -$165K – 89
2022
Q4 		$165K Sell
228
-229
-50% -$169K 0.08% 67
2022
Q3 		$315K Buy
457
+16
+4% +$10.1K 0.15% 64
2022
Q2 		$261K Buy
441
+64
+17% +$41.6K 0.12% 67
2022
Q1 		$263K Buy
377
+196
+108% +$124K 0.1% 70
2021
Q4 		$114K Buy
181
+165
+1,031% +$101K 0.04% 78
2021
Q3 		$10K Sell
16
-2
-11% -$1.24K ﹤0.01% 94
2021
Q2 		$10K Buy
+18
New +$9.12K ﹤0.01% 167

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return